Paul Ciubotaru

Dr. Paul Ciubotaru

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VIVlad Ivan
Vlad Ivan
Roxana BuzasRoxana Buzas
Roxana Buzas
ACAdina-Flavia Cutina-Morgovan
Adina-Flavia Cutina-Morgovan
PCPaul Ciubotaru
Paul Ciubotaru
MAMelania Ardelean
Melania Ardelean
DLDaniel Lighezan
Daniel Lighezan
Study basis: As a byproduct of protein metabolism, serum uric acid is a controversial risk factor and is the focus of several recent studies in the field of cardiovascular disease. Whether serum uric acid is involved in the development of these pathologies alone or in conjunction with other factors is a matter of debate. Objective: The objective of this study is to assess the direct relationship between serum uric acid and the ejection fraction. Methods: A retrospective study of 303 patients with heart failure, classified according to the ESC guidelines, was conducted, and several parameters, along with the relationship between serum uric acid and ejection fraction, were characterized. Results: A direct relationship between the level of serum uric acid and the ejection fraction was established (p = 0.03); patients with higher uric acid had an increased risk of having a lower ejection fraction. Conclusions: Serum uric acid, even when asymptomatic, is linked with the level of the ejection fraction of the left ventricle.